Methods for inhibiting preterm labor and uterine contractility disorders and preventing cervical ripening

a technology of uterine contractility and inhibiting uterine contractions, which is applied in the direction of pharmaceutical delivery mechanisms, medical preparations, oil/fat/waxes non-active ingredients, etc., can solve the problems of increasing the cost of neonatal and long-term care of preterm infants, affecting the health of individual families, and affecting the health of preterm infants. , to achieve the effect of inhibiting uterine contractions and cervical ripening, preventing
US20130023505A1Inactive Publication Date: 2013-01-24DIGNITY HEALTH

Patent Information

Authority / Receiving Office
US · United States
Patent Type
Applications(United States)
Current Assignee / Owner
DIGNITY HEALTH
Publication Date
2013-01-24
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention relates to methods and pharmaceutical compositions for inhibiting or preventing preterm birth, inhibiting or delaying cervical ripening, inhibiting myometrial contractility and treating or inhibiting uterine contractility disorders. The methods comprise administering an effective amount of a composition comprising steroid hormones such as soluble progesterone.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] This application is a continuation-in-part of, and includes a claim of priority under 35 U.S.C. §120 to, International Application No. PCT / US2011 / 027788, filed on Mar. 9, 2011, which designated the U.S. and that International Application was published under PCT Article 21(2) in English. This application also includes a claim of priority under 35 U.S.C. §119(e) to U.S. Ser. No. 61 / 311,944 filed Mar. 9, 2010 and to U.S. Ser. No. 61 / 434,309 filed Jan. 19, 2011, the contents of all of which are herein incorporated by reference.FIELD OF INVENTION

[0002] The invention relates to methods for inhibiting or preventing preterm birth, delaying cervical ripening, inhibiting myometrial contractility and treating uterine contractility disorders, in subjects in need thereof. The method comprises administering an effective amount of a steroid hormone such as progesterone or a pharmaceutical equivalent, analog, derivative or a salt thereof. The invention also relates to pharmaceutical compositio...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More